Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Allen

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|February 16, 2022
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 InhibitorsRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|June 26, 2023
Discovery of pyrrolo[2,1-<i>f</i>][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of painCarolyn D Dzierba, Bireshwar Dasgupta, George Karageorge, et al.
Journal of Medicinal Chemistry|March 9, 2022
Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|February 16, 2022
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 InhibitorsRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|June 26, 2023
Discovery of pyrrolo[2,1-<i>f</i>][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of painCarolyn D Dzierba, Bireshwar Dasgupta, George Karageorge, et al.
Journal of Medicinal Chemistry|March 9, 2022
Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Pageof 5